Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More
Hutch News Stories

Cancer immunotherapy: What do you know about it?

From checkpoint inhibitors to cancer vaccines, learn about a field that is revolutionizing cancer research
Video by Sabrina Richards and Breanna Welch / Fred Hutch News Service

Fred Hutch’s Nobel Prize-winning work on bone marrow transplantation provided the first definitive and reproducible example of the human immune system’s power to cure cancer.

Today, the Hutch continues to lead this revolutionary field — immunotherapy — which harnesses the immune system to overcome cancer.

In this brief video, learn how our researchers have been exploring better ways to employ components of the immune system — from small proteins to cancer-killing T cells — to improve cancer care.

Related News

All news >
Bezos family gives $35 million to Fred Hutch ‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients March 30, 2017
93 percent of advanced leukemia patients in remission after immunotherapy ‘Exciting’ but early results from trial of engineered immune cells April 25, 2016
6 questions in cancer immunotherapy From cancer vaccines to engineered T cells, experts weigh in on the big unknowns March 18, 2016

Help Us Eliminate Cancer

Every dollar counts. Please support lifesaving research today.

Last Modified, September 21, 2021